Kodiak Sciences (KOD) Retained Earnings (2017 - 2026)
Kodiak Sciences (KOD) posted Retained Earnings of -$1.6 billion for Q1 2026, down 3.73% on a QoQ basis from -$1.6 billion in Q4 2025, and down 16.64% year-over-year from -$1.9 billion in Q1 2025.
Kodiak Sciences (KOD) Retained Earnings (2017 - 2026) Analysis & Trends
Kodiak Sciences' Retained Earnings history runs 10 years deep, the most recent figure standing at -$1.6 billion for Q1 2026.
- Quarterly Retained Earnings fell 16.64% year-over-year to -$1.6 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.6 billion (down 16.64% YoY) and the FY2025 annual result came in at -$1.6 billion, down 17.31% from the prior year.
- Retained Earnings was -$1.6 billion for Q1 2026 at Kodiak Sciences, down from -$1.6 billion in the prior quarter.
- Across five years, Retained Earnings topped out at -$1.3 million in Q4 2022 and bottomed at -$1.6 billion in Q1 2026.
- A 5-year average of -$1.1 billion and a median of -$1.2 billion in 2024 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings sank 3633022.22% — and 2024, when it slipped 15.29%.
- Kodiak Sciences' Retained Earnings stood at -$1.3 million in 2022, then plunged by 88081.41% to -$1.2 billion in 2023, then declined by 15.29% to -$1.3 billion in 2024, then retreated by 17.31% to -$1.6 billion in 2025, then fell by 3.73% to -$1.6 billion in 2026.
- Business Quant data shows KOD's Retained Earnings at -$1.6 billion in Q1 2026, -$1.6 billion in Q4 2025, and -$1.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - | -1.62 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.62 Bn |
| Dec 31, 2025 | -1.56 Bn |
| Sep 30, 2025 | -1.50 Bn |
| Jun 30, 2025 | -1.44 Bn |
| Mar 31, 2025 | -1.39 Bn |
| Dec 31, 2024 | -1.33 Bn |
| Sep 30, 2024 | -1.28 Bn |
| Jun 30, 2024 | -1.24 Bn |
| Mar 31, 2024 | -1.20 Bn |
| Dec 31, 2023 | -1.15 Bn |
| Mar 31, 2023 | -962.82 Mn |
| Dec 31, 2022 | -1.31 Mn |
| Sep 30, 2022 | -821.59 Mn |
| Jun 30, 2022 | -1.87 Mn |
| Mar 31, 2022 | -653.93 Mn |
| Sep 30, 2021 | -465.05 Mn |
| Mar 31, 2021 | 18,000.00 |
| Dec 31, 2020 | -291.23 Mn |
| Sep 30, 2020 | 245,000.00 |
| Jun 30, 2020 | 594,000.00 |